ArticleCell reports. Medicine2022

Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer.

Katrin J Frank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.